Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

949
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
949
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.6K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of guidelines, legislation, litigation and mechanisms for SUDEP communication in the UK and in the USA: A state-of-the-art review.

Seizure·2026
Same author

Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice.

ClinicoEconomics and outcomes research : CEOR·2026
Same author

Patient and practitioner workshops for an intellectual disabilities and epilepsy neuropsychiatric genetic research database register: Ethical dilemmas for study design.

Seizure·2026
Same author

Sarcopenia: effects of Robuvit® supplementation on loss of muscular mass and strength.

Minerva medica·2026
Same author

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial.

Lancet (London, England)·2026
Same author

The iTrail making test (iTMT): an evaluation of novel testing paradigms, hidden indices of measurement, and diagnostic accuracy in Parkinson's disease.

Journal of clinical and experimental neuropsychology·2026

Related Experiment Video

Updated: Mar 27, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K

Keeping patients with epilepsy safe: a surmountable challenge?

Rohit Shankar1, Craig Newman1, Jane Hanna1

  • 1Cornwall Partnership NHS Foundation Trust.

BMJ Quality Improvement Reports
|January 7, 2016
PubMed
Summary

Discussions about sudden unexpected death in epilepsy (SUDEP) are crucial for people with epilepsy (PWE). A new checklist and telehealth approach significantly increased SUDEP risk discussions from 10% to 80% in PWE.

More Related Videos

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

2.9K
Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
07:31

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Published on: May 7, 2020

8.1K

Related Experiment Videos

Last Updated: Mar 27, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

2.9K
Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
07:31

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Published on: May 7, 2020

8.1K

Area of Science:

  • Neurology
  • Quality Improvement
  • Patient Safety

Background:

  • Sudden unexpected death in epilepsy (SUDEP) is a significant concern for people with epilepsy (PWE).
  • Discussions regarding SUDEP risk and prevention are inconsistently documented, despite existing guidance.
  • Current approaches to SUDEP discussions lack structure and evidence-based, person-centered strategies.

Purpose of the Study:

  • To implement and evaluate a structured approach for discussing SUDEP with newly diagnosed people with epilepsy (PWE).
  • To improve the documentation rate of SUDEP discussions within intellectual disability teams.
  • To enhance patient and carer knowledge and awareness of SUDEP risk factors.

Main Methods:

  • A quality improvement project was initiated, involving the development and implementation of a SUDEP risk factor checklist.
  • The checklist was refined and subsequently utilized via telehealth consultations with patients and their carers.
  • Data was collected pre- and post-intervention to assess the rate of recorded SUDEP discussions.

Main Results:

  • The documentation rate of SUDEP discussions increased significantly from 10% to 80% following the intervention.
  • Telehealth, utilizing a checklist approach, proved effective in facilitating these crucial conversations.
  • Positive feedback was received from patients, carers, and healthcare professionals.

Conclusions:

  • A structured, checklist-based telehealth intervention markedly improved SUDEP discussion rates in people with epilepsy (PWE).
  • This approach enhances patient and carer engagement and knowledge regarding SUDEP.
  • Future development includes a mobile application for ongoing risk monitoring and patient empowerment.